Department of Science
and Technology

PI -Understanding role of Lipid-Protein interactions during life cycle of Plasmodium vivax

10/15/2023-09/15/2026

65,00,000 INR

Indian Council of Medical Research

"Quantitative signatures of circulating small non coding RNA5 for diagnosis of pulmonary tuberculosis and latent TB infection"

01/05/2025-31/04/2027

99,00,000 INR

DBT/Wellcome Trust India Alliance's

Co-PI Identification of key ligands/ligand complexes on Plasmodium falciparum merozoite using Cryo EM, proteome and immunological approaches-A step towards the development of an efficacious malaria blood stage vaccine

01/10/2023-31/09/2028

9,65,000,00 INR

Department of Science
and Technology

Co-PI Understanding key regulators of Mitochondrial Dynamics and homeostasis in human malaria parasite Plasmodium falciparum

01/08/2023-30/09/2026

53,00,000 INR

Ministry of HRD Scheme for Transformational and Advanced Research in Sciences (STARS)

Single-cell quantitation of mRNA and protein expression of antigenic variation genes and tissue tropism characterization in Plasmodium falciparum

01/06/2023-31/12/2026

25,00,000 INR

AIIMS Interdepartmental Intramural

A longitudinal study to assess the incidence of chronic pulmonary aspergillosis in pulmonary tuberculosis patients and identification of Aspergillus immunodiagnostic antigens

01/07/2023-31/06/2025

10,00,000 INR

Indian Council of Medical Research (ICMR)

Characterization of host pathogen interaction during P. Vivax infection

01/10/2019-31/09/2022

65,00,000 INR

DBT-Bill and Melinda gates Foundation Grand Challenge Award

Principal Investigator-miRNA as Evaluation Biomarker of Tuberculosis treatment Response

01/06/2017-31/12/2918

50,00,000 INR

Department of Science and Technology

Principal Investigator-To understand Mechanism of Organelle Dynamics in Plasmodium falciparum: involvement of Autophagy

01/06/2013-31/05/2018

35,000,00 INR

Department of Biotechnology –CNRS France

Co-PI Understanding organelle dynamics in Apicomplexan parasites to identify novel drug targets

01/01/2025-31/06/2016

30,000 Euro